eculizumabnarsopilmabpegcetacoplanrituximabdefibrotidenomacopanravulizumabJACIE-accredited BMT centrestransfusions
…een put forward for consideration in treating high-risk TA-TMA; eculizumab, narsopilmab, rituximab, defibrotide, ravulizumab, nomacopan, p…